As the world celebrates International Moon Day (20 July), Switzerland is championing the opportunities space exploration opens for life sciences. Leading international players including Starlab Space and Axiom Space have selected Switzerland as their European hub for the next generation of commercial orbital laboratories, supporting R&D in… Read More
The Swiss biotech industry recorded its highest ever revenues in 2025, a new report shows. The 2026 Swiss Biotech Report says the industry saw record revenues of CHF 7.5 billion (€8.2 billion) in 2025, up from CHF 7.2 billion (€7.9 billion) in 2024. Employment in… Read More
Swiss Biotech Day, first launched in 2021, will be held this year at Congress Center Basel on 4-5 May. The day provides a chance to explore advances in R&D, manufacturing, data management, AI and innovative financing. The 2026 Plenary Sessions will include a fireside session… Read More
Swiss Biotech Day, first launched in 2021, will be held this year at Congress Center Basel on 4-5 May. The event has seen remarkable growth every year and has become a key global biotechnology conference for life sciences professionals, fostering international collaboration and impactful partnerships. … Read More
Biotechnology company TECregen has appointed Dr Klaas Zuideveld as Chief Executive Officer. Zuideveld will lead the company’s strategy and execution as the company advances its thymopoietic biologics designed to rejuvenate thymic epithelial cells (TECs), restore immune function, and strengthen immune resilience. Zuideveld arrives with experience across large pharmaceutical companies and biotech, spanning translational strategy,… Read More
US President Donald Trump has sent letters to the leaders of 17 major pharmaceutical companies outlining how they should slash US prescription drug prices to match those paid overseas, the White House said on Thursday. Trump signed an executive order in May demanding drugmakers… Read More
A new report has spotlighted how Switzerland has become one of the world’s most advanced Deep Tech ecosystems, led in part by the rise in the number of techbio start-ups in the country. The Swiss Deep Tech Report 2025, a Deep Tech Nation Switzerland initiative, was curated… Read More
In September 2024, DDW’s Megan Thomas attended the opening of the Genolier Campus, a campus that includes the Clinique de Genolier, the Genolier Innovation Hub, the Clinique Nescens and the Swiss Visio Network. The campus is dedicated to medical research, innovation and the training of healthcare professionals. … Read More
The Swiss Agency for Therapeutic Products (SwissMedic) has granted Orphan Drug Status (ODS) to 4SC’s Kinselby (resminostat) for the treatment of cutaneous T-cell lymphoma (CTCL). In Switzerland, ODS provides privileged status to drugs that show promise for the treatment of rare diseases and qualifies 4SC for… Read More
DDW’s Diana Spencer takes a closer look into why Switzerland is such a life sciences powerhouse and how Swiss researchers are advancing new technology and tackling modern health challenges. OECD data places Switzerland second in the world for biotechnology R&D intensity1, and in 2021, the country… Read More
DDW’s Diana Spencer takes a closer look into why Switzerland is such a life sciences powerhouse and how Swiss researchers are advancing new technology and tackling modern health challenges. OECD data places Switzerland second in the world for biotechnology R&D intensity1, and in 2021, the country… Read More
Thanks to a prestigious academic legacy, Europe has long been a dominant region for life sciences. In this article, DDW’s Diana Spencer highlights several prominent hotspots that are taking the lead on advancing European drug discovery and development. Europe is traditionally a life sciences powerhouse, with a strong tradition in… Read More
